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ABSTRACT 
Recent developments in fast dissolving/disintegrating tablets have brought convenience in dosing to elderly and children who have trouble in 
swallowing tablets. The objective of the present study was to prepare the mouth disintegrating tablet of ketoprofen (NSAID). As precision of 
dosing and patient's compliance become important prerequisite for a long term NSAID treatment, there is a need to develop a formulation for 
this drug which overcomes problems such as difficulty in swallowing, inconvenience in administration while travelling and patient's 
acceptability. Hence, the present investigation was undertaken with a view to develop a fast disintegrating tablet of ketoprofen which offers a 
new range of product having desired characteristics and intended benefits. The drug is poorly water soluble therefore to enhance the solubility 
and release of drug, solid dispersion of drug with mannitol was prepared by melt solvent method and melting method. In addition, the physical 
mixture was prepared for comparison. Different superdisintegrants such as croscarmellose sodium, sodium starch glycolate, crospovidone 
were used. Directly compressible mannitol was used as a carrier and to enhance the mouth feel and taste. The tablets were prepared by direct 
compression technique on rotary tablet machine. The tablets were evaluated for hardness, friability, weight variation, wetting time, dispersion 
time and uniformity of content and in vitro dissolution test. All the tablets had hardness 3-4.5 kg/cm2 and friability of all formulations was less 
than 1%, weight variation and drug content were within official limit.  
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INTRODUCTION 
The fast dissolving tablets usually dissolve in the oral cavity 
within 15 seconds to 3 minutes. In another words a fast-
dissolving tablet is tablet that dissolves or disintegrates in 
the oral cavity without the need of water or chewing1. It is 
advantageous because of ease of administration to 
pediatrics, geriatrics and psychiatric patient, free from the 
risk of suffocation due to physical obstruction when 
swallowing, no need of water to swallow2-4 etc. However, 
there it certain limitations like Drugs with relatively larger 
doses are difficult to formulate into FDT e.g. antibiotics like 
ciprofloxacin with adult dose tablet containing about 500 
mg of the drug, Patients who concurrently take anti-
cholinergic medications may not be the best candidates for 
FDT. Similarly patients with Sjögren's syndrome or dryness 
of the mouth due to decreased saliva production may not be 
good candidates for this tablet formulations5-7. 
The drug Ketoprofen having Chemical name- 2-(3-
benzoylphenyl)-propionic acid, 3-Benzoyl--
methylbenzeneacetic acid and Molecular formula- 
C16H14O3,.Ketoprofen inhibit the cyclooxygenase which 
results in various beneficially effects  like analgesia, 
antipyresis, anti-inflammatory, antithromotic and closure of 
ductus arteriosus. Ketoprofen is used in treatment of 
rheumatoid arthritis, osteoarthritis, dysmenorrhea and 
management of pain.  
Bioavailability of ketoprofen is limited because of its poor 
water solubility following oral administration. Ketoprofen 
was also reported to cause local gastrointestinal side effects 
which require withdrawal of treatment .Therefore, several 
solubilization techniques were applied and reported to 
enhance the aqueous solubility of ketoprofen. For improving 
the solubility and dissolution rate of the drug in water, 
formation of inclusion complexes with cyclodextrin and 
skimmed milk were carried out. To enhance the dissolution 
rate and bioavailability of ketoprofen, a novel dry elixir 
dosage form has been proposed. The formation of 
ketoprofen solid dispersions and ketoprofen-dextran ester 
prodrug has been reported to improve ketoprofen solubility 
and dissolution and to reduce its ulcerative side effects. 
Solid dispersions are widely used to improve the water 
solubility and dissolution of many drugs and are 
traditionally prepared using fusion or solvent techniques.  
Both techniques suffer from a number of disadvantages8. 
In our study we prepare solid dispersion of Ketoprofen by 
Melt Fusion Technique have been reported to have more 
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advantages over other available techniques. In this 
technique, we prepare physical mixture and solid dispersion 
of drug in combination with Polaxomar-188 and evaluate 
both the combinations on different parameters .Thereafter; 
we prepare Fast Dissolving Tablet By using different 
superdisintegrants like Ac-Di-Sol, Sodium starch glycolate, 
Crospovidone and Effervescent agents.  
MATERIAL AND METHOD 
Materials 
We have purchased drug and excipients such as Ketoprofen, 
Poloxamer-188, Ac-Di-Sol, Sodium Starch Glycolate, 
Crospovidone, Sodium Bicarbonate, Citric Acid, Avicel PH 
102, Lactose, Dextrose, Magnesium Stearate, Talc, Sodium 
Phosphate, Sodium Hydroxide, Menthol LR, Acetone LR 
from various industries like Cadila Pharmaceuticals, 
Ahmedabad, Signel Chemicals Pvt. Ltd. , Mumbai, Central 
Drug House (P) Ltd., Mumbai, E. Merch (India) Ltd., Mumbai, 
S. D. Fine Chem Limited Mumbai. All water used was 
distilled and De-ionized. All the chemicals were reagent 
grade and used as received. 
Methods 
1.1 Preparation of physical mixtures of ketoprofen 
Physical mixtures of Ketoprofen(KP) were prepared using 
Poloxamer 188 as a carrier in a weight ratio. First drug and 
carrier were passed through a 40 mesh screen and then 
weighed and mixed by using motor and pestle (Table 1).  
Table 1 Composition of Ketoprofen-Poloxamer 188 Physical 
Mixture 
Formulation Number Drug : Carrier weight ratio 
KP1 1:2 
KP2 1:4 
KP3 1:6 
KP4 1:8 
KP5 1:10 
1.2 Preparation of solid dispersions of ketoprofen 
Melt fusion method was used to prepare solid dispersions of 
Ketoprofen (KS). Table 8.3 depicts the composition for 
preparing solid dispersions of poloxamer 188 in various 
ratios. Ketoprofen and poloxamer 188 were weighed 
according to these weighed ratios. Poloxamer 188 was 
melted at 600C. In this melted poloxamer 188, Ketoprofen 
was added. It was mixed well and flashed cooled on an ice 
bath and then stored over night in a dessicator. The 
prepared solid dispersion was then grounded by using a 
mortar and pestle, sieved through a mesh 40 and stored 
over a fused calcium chloride in a dessicator for further use. 
9 (Table 2) 
Table 2 Composition of Ketoprofen-Poloxamer 188 Solid 
Dispersions 
Formulation Number Drug : Carrier ratio 
KS1 1:2 
KS2 1:4 
KS3 1:6 
KS4 1:8 
KS5 1:10 
 
1.3 Formulation of fast dissolving tablets 
Fast dissolving tablets containing selected solid dispersion 
were prepared by direct compression method using single 
punch tablet machine to produce convex faced tablets 
weighing 500 mg each with a diameter of 11 mm. A 
minimum of 100 tablets were prepared for each batch. The 
formulations were developed by using different techniques. 
1.3.1 By Addition of Super Disintegrants 
The superdisintegrants (Ac-Di-Sol, Sodium starch glycolate 
and Crospovidone) in varying concentration (1-5%) were 
used to develop the tablets. All the ingredients were shown 
in Table 8.6-8.8 were passed through sieve no. 60 and were 
co- grounded in a glass pestle motor. These blends were 
evaluated for mass-volume relationship (Bulk Density, 
Tapped Density, Hausners Ratio, Compressibility Index) and 
flow properties (Angle of Repose). The mixed blend of 
excipients was compressed using a single punch tablet 
machine (Cadmach, Ahmedabad) to produce convex faced 
tablets weighing 500 mg each with a diameter of 11 mm. 
(Table 3-5) 
Table 3 Formulation of Fast Dissolving Tablet Using Ac-Di-Sol 
Ingradient F1 F2 F3 F4 F5 
KS2 250 250 250 250 250 
Ac-Di-Sol 5 10 15 20 25 
Lactose 70 70 70 70 70 
Dextrose 70 70 70 70 70 
Avicel PH 102 135 130 125 120 115 
Talc 10 10 10 10 10 
Magnesium Stearate 10 10 10 10 10 
 
Table 4 Formulation of Fast Dissolving Tablet Using Sodium Starch Glycolate 
Ingredients F6 F7 F8 F9 F10 
KS2 250 250 250 250 250 
Sodium starch glycolate 5 10 15 20 25 
Lactose 70 70 70 70 70 
Dextrose 70 70 70 70 70 
Avicel PH 102 135 130 125 120 115 
Talc 10 10 10 10 10 
Magnesium Stearate 10 10 10 10 10 
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Table 5 Formulation of Fast Dissolving Tablet Using Crospovidone 
Ingredients F11 F12 F13 F14 F15 
KS2 250 250 250 250 250 
Crospovidone 5 10 15 20 25 
Lactose 70 70 70 70 70 
Dextrose 70 70 70 70 70 
Avicel PH 102 135 130 125 120 115 
Talc 10 10 10 10 10 
    Magnesium Stearate 10 10 10 10 10 
 
1.3.2 By Effervescence Technology 
Fast dissolving tablets were prepared by using Citric acid 
and Sodium bicarbonate in combination in (2:3 ratio) with 
other excipients shown in Table 8.9 was co-grounded in 
glass pestle and mortar. These tablets contain (1-5%) 
effervescent agent in various proportion. These blends were 
evaluated for mass-volume relationship (Bulk Density, 
Tapped Density, Hausners Ratio, Compressibility Index) and 
flow properties (Angle of Repose). The mixed blends of 
excipient were compressed using a single punch machine 
(Cadmach, Ahmedabad) to produce convex faced tablets 
weighing 300 mg each with a diameter of 11 mm. (Table 6) 
 
Table 6 Formulation of Fast Dissolving Drug Free Tablet Using Effervescent Agents 
Ingradient F16 F17 F18 F19 F20 
KS2 250 250 250 250 250 
Citric Acid 2 4 6 8 10 
Sodium Bicarbonate 3 6 9 12 15 
Lactose 70 70 70 70 70 
Dextrose 70 70 70 70 70 
Avicel PH 102 135 130 125 120 115 
Talc 10 10 10 10 10 
Magnesium Stearate 10 10 10 10 10 
 
 
Evaluation Parameters: 
2.1 IR spectra show is showing the authenticity of procured 
sample of drug Ketoprofen (Figure-1A and 1B). 
2.2 Ultraviolet Absorption Maxima: Ultraviolet absorption 
in the rage 200 to 400 nm of a 5g/ml solution in 5% (v/v) 
methanolic Sorensons Buffer (pH 6.8) was measured. The 
absorption maxima (λmax) of Ketoprofen (5 µg/ml) in this 
solution was found to be 260 nm which is concordant with 
the Indian Pharmacopoeia (1996) shown in (Figure-2). 
3. Preformulation Studies 
3.1 Solubility 
The solubility of Ketoprofen was determined in different 
solvent systems and buffers. An excess quantity of the drug 
was mixed with 10 ml of each solvent in screw capped glass 
tubes and shaken on constant water bath shaker for 24 
hours at 25o. The solutions were examined physically for the 
absence or presence of drug particles and also by 
spectrophometrically for quantitative determination of drug 
in buffers. The drug is highly soluble in Methanol and 
Ethanol. 
3.2 Drug Polymer Interaction Studies 
The infrared absorption spectra of pure polymer and 
physical mixture of polymer and drug were performed for 
polymer drug interaction studies between 4000 cm-1-500 
cm-1 placed at 40 ± 50C and 75 ± 5% RH for 4 weeks. The IR 
spectra of physical mixture of polymers and drug were 
shown in Figure 6.5-6.7. Physical changes and absorption 
maxima were also evaluated (Figure-3,4,5). 
 
4. Characterization of fast dissolving tablets 
After compression of powder, the tablets were evaluated for 
organoleptic characteristics like color, odor, taste, diameter, 
thickness and physical characteristics like hardness, 
friability, disintegration time, wetting time, dispersion time 
and dissolution studies. The results were shown in Table 7-
8, Figure-6. 
4.9 Content Uniformity  
Ten randomly selected tablets were weighed and powdered 
in a glass mortar pestle. The weight equivalent to 10 mg 
Ketoprofen was weighed and dissolved in 5 ml of methanol 
in volumetric flask using magnetic stirrer, the volume was 
adjusted to 100 ml with Sorenson’s buffer (pH 6.8) and the 
solution was filtered. An aliquot of 1.0 ml of solution were 
diluted to 10 ml Sorenson’s buffer (pH 6.8) in separate 
volumetric flask. The content in was determined 
spectrophotometrically at 260 nm. The results were shown 
in Table 9. 
4.10 In-vitro dissolution studies:  
In vitro dissolution studies of formulation were carried out 
using USP paddle method at 50 rpm in 900 ml of Sorenson’s 
buffer (pH 6.8) as dissolution media, maintained at 
37±0.50C. 5 ml of aliquot was withdrawn at the specified 
time intervals, filtered through whatmann filter paper and 
analysed spectorphotometrically at 260 nm. An equal 
volume of fresh medium, which was prewarmed at same 
condition was replaced into the dissolution media after each 
sampling to maintain the constant volume throughout the 
test. 
 
 
Sisodiya et al                                                                                                          Journal of Drug Delivery & Therapeutics. 2018; 8(6-A):85-92  
ISSN: 2250-1177                                                                                  [88]                                                                                 CODEN (USA): JDDTAO 
5. RESULT AND DISCUSSION                     . 
In the present project FDT of Ketoprofen were prepared and 
evaluated for achievement of fast action of active moiety. 
The tablets were prepared by direct compression method 
by using solid dispersion technology. Fast disintegration of 
tablets was achieved by using superdisintegrants and 
effervescent agents. The Ketoprofen is water insoluble drug 
so this is necessary to increase the water solubility of the 
drug for that purpose firstly the solid dispersion of 
Ketoprofen were prepared and evaluated. The optimized 
solid dispersion were incorporated in FDTs. These prepared 
tablets were evaluated for their quality control parameter.  
The FT-IR spectra verified the authenticity of the procured 
sample(Figure 1A,1B).characteristics peak of Ketoprofen 
are present at 1696 cm-1 and 1657cm-1 in sample spectra. 
The absorption maxima of Ketoprofen was observed at 260 
nm in 5% methanolic Sorenson’s buffer, which is 
concordant with the value given in IP 1996. The UV spectra 
of Ketoprofen was shown in Figure 2. The maximum 
solubility was found in methanol and ethanol and least in 
distilled water. Drug-polymer interaction study was carried 
out by FT-IR. Results were shown in Figure 3-5. Both the 
drug and polymers were compatible with each other. Hence 
the drug and polymers can be successfully incorporated in 
the design of solid dispersion as well as fast dissolving 
tablets. 
 
Figure-1A 
 
Figure-1B 
 
Figure 1 IR Spectra (A) Ketoprofen IP Spectra and (B) Sample of Ketoprofen 
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Figure-2 Scan Graph of Ketoprofen 
 
Figure 3 IR Spectra of Mixture of Drug and Ac-Di-Sol 
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Figure 4 IR Spectra of Mixture of Drug and Sodium Starch Glycolate 
 
Figure 5 IR Spectra of Mixture of Drug and Crospovidone 
 
Physical mixtures and solid dispersions of Ketoprofen with 
poloxamer 188 (1:2 to 1:10) were prepared by melt fusion 
technique, the prepared PM and SD were evaluated for drug 
content, solubility, IR. The composition of various 
formulations of physical mixtures and solid dispersion were 
shown in Table 1 and 2. 
It was observed that the saturation solubility of drug was 
increased by 20 to 50 folds by converting the drug into solid 
dispersion, due to change in physical state of Ketoprofen 
from crystalline to amorphous state which was confirmed 
by the IR, studies. Enhanced solubility of Ketoprofen from 
solid dispersions prepared from poloxamer 188 could be 
correlated to the chemical structure of highly water soluble 
poloxamer 188. Poloxamer 188 consists of ethylene oxide 
(EO) and propylene oxide (PO) blocks. These blocks results 
in an amphiphilic nature of poloxamer, which has the 
properties to self-assemble into micelles in aqueous 
solution; the hydrophobic core (PO block) can act as 
reservoir for the drug, while the hydrophilic portion (EO) 
acts as interface between the aqueous medium and the drug. 
At low concentrations, approximating those at which more 
conventional nonionic detergents form micelles, the 
poloxamer monomers are thought to form monomolecular 
micelles by a change in configuration in solution. At higher 
concentration, these monomolecular micelles associate to 
form aggregates of varying size, which have the ability to 
solubilize drugs and to increase the stability of solubilized 
agents. 
Several mechanisms may be possible for the enhanced 
release of Ketoprofen in the solid dispersion formulation 
with the water soluble polymeric surfactant poloxamer 188.  
In the dry state, drug particles were in close contact or 
adhered to the polymer particles as a result of mixing 
(supported by IR). When the mixture comes in contact with 
water, the polymer particles might have hydrated rapidly 
into polymer solution solubilizing the adjacent drug 
particles and subsequently releasing the drug into the 
medium.  
Dissolution efficiency of pure Ketoprofen and all the 
physical mixtures and solid dispersion formulations at 6 
minutes and 10 minutes were calculated . As the dissolution 
time was increased from 6 to 10 minutes, the dissolution 
efficiency was increased in all the formulations. Among the 
formulations KS2 has shown maximum dissolution 
efficiencies of 46.61% and 48.27% respectively. However, 
KP1, KP2, KP3, KP4, KP5, KS1, KS3, KS4 and KS5 also 
produce comparable results on terms of dissolution 
efficiency.  
From the above characterization of solid dispersions the 
KS2 (solid dispersion of Ketoprofen with poloxamer 188 in 
ratio 1:4) found to be more approachable for incorporation 
in fast dissolving tablets due to the high saturation solubility 
in low concentration of poloxamer 188. 
In the present study, total twenty drug formulations were 
formulated using KS2 (Solid dispersion). Ingredients for 
prepared tablets are shown in Table 3-6.  
The thickness of the tablet was found 6.321-6.372 mm. The 
average weight of the prepared tablet was found 494.7-
501.6 mg. So it was predicted that all the tablets exhibited 
uniform weight with low standard deviation values within 
the acceptable variation as per IP. The results are shown in 
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Table 7. The friability of all the formulations was found to be 
less than 1.0 %, which indicates the tablet’s ability to 
withstand abrasion in handling, packaging and shipment. 
The hardness of tablet were varied from 2.5-3.7 kg/cm2 
(Table 7), which has satisfactory strength to withstand with 
the applied mechanical shocks. Friability of F5, F11, F19 and 
F20 are found very near to one so these formulations are 
not forwarded for further studies. 
 In the formulation of fast dissolving tablet the three 
superdisintegrants (Ac-Di-Sol, Sodium Starch Glycolate and 
Crospovidone) and effervescent agent (Citric acid and 
Sodium bicarbonate) were used in different concentrations. 
The tablets with Crospovidone disintegrate faster then the 
tablets with the Citric acid, Sodium Starch Glycolate and Ac-
Di-Sol. 
The disintegration time of all the formulations were found 
between 12.33±1.52 s to 57.00±2.64 s except F1, F2, F3, F6, 
F7 and F16. The results were shown in Table 8. 
 
Table 7 Characterization of Fast Dissolving Tablets 
Parameters Thickness Weight Fribility Hardness 
Formulations (mm) (mg) (%) (kg/cm2) 
F1 6.325±0.014 498.8±3.551 0.42±0.033 3.1±0.152 
F2 6.342±0.026 494.7±3.632 0.47±0.037 3.0±0.096 
F3 6.343±0.034 496.2±4.427 0.62±0.042 2.8±0.126 
F4 6.325±0.004 496.8±3.321 0.73±0.039 2.8±0.134 
F5 6.349±0.037 499.1±2.731 0.94±0.051 2.7±0.157 
F6 6.342±0.029 498.5±3.654 0.72±0.055 3.1±0.095 
F7 6.348±0.043 500.4±4.246 0.44±0.038 3.7±0.125 
F8 6.349±0.021 497.9±3.176 0.80±0.049 3.0±0.133 
F9 6.334±0.034 499.2±2.923 0.66±0.053 3.2±0.113 
F10 6.325±0.008 501.6±3.765 0.49±0.060 3.6±0.109 
F11 6.345±0.016 496.4±3.874 0.96±0.057 3.4±0.165 
F12 6.372±0.031 497.6±3.652 0.73±0.047 3.2±0.187 
F13 6.346±0.034 495.8±4.233 0.61±0.052 3.6±0.126 
F14 6.335±0.031 496.8±3.522 0.48±0.043 3.1±0.123 
F15 6.348±0.031 497.1±2.672 0.47±0.062 3.3±0.165 
F16 6.344±0.034 497.9±3.176 0.57±0.043 2.6±0.093 
F17 6.363±0.035 501.3±3.765 0.68±0.029 2.7±0.133 
F18 6.343±0.016 498.3±3.551 0.81±0.059 2.8±0.183 
F19 6.366±0.041 497.3±3.654 0.93±0.034 2.5±0.165 
F20 6.321±0.339 500.4±4.246 0.96±0.072 2.7±0.165 
Data are expressed as mean  S.D. (n = 3) 
Table 8 Characterization of Fast Dissolving Tablets 
Parameters Disintegration Time Wetting Time Dispersion Time 
Formulations (Seconds) (Seconds) (Seconds) 
F1 93.33±1.52 88.66±4.50 109.66±5.85 
F2 88.00±3.00 78.00±3.60 99.66±4.72 
F3 68.00±2.64 64.33±2.51 81.00±4.58 
F4 57.00±2.64 51.66±2.51 66.33±5.13 
F5 51.33±2.08 45.66±1.52 56.33±3.05 
F6 127.00±4.58 114.00±5.00 138.66±8.50 
F7 109.66±8.02 101.33±4.93 121.33±6.42 
F8 57.00±5.56 79.33±5.68 76.33±6.42 
F9 44.66±2.08 55.33±3.21 56.33±5.13 
F10 34.66±1.52 41.66±4.04 43.33±4.04 
F11 35.66±2.51 41.66±2.08 41.66±3.51 
F12 30.33±1.52 35.66±1.52 36.33±2.51 
F13 24.33±2.08 27.66±2.08 28.33±3.05 
F14 20.66±1.52 22.66±1.15 23.33±2.08 
F15 12.33±1.52 19.00±1.00 19.33±1.52 
F16 60.66±3.51 58.33±3.05 62.33±4.50 
F17 44.33±2.08 39.33±3.05 46.33±3.05 
F18 34.33±2.51 36.33±2.30 37.33±3.51 
F19 24.66±2.08 28.33±1.52 25.66±2.08 
F20 20.66±1.52 24.00±1.00 22.66±2.51 
Data are expressed as mean  S.D. (n = 3) 
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Figure 6 Effect of Concentration of Superdisintegrant and Effervescent Agent on Disintegration Time 
Table 9 Drug Content in the Fast Dissolving Tablet of Ketoprofen 
Parameters Drug Content Drug Content 
Formulations (mg per Tablet) % 
F1 10.183 101.83 
F2 10.208 102.08 
F3 10.108 101.08 
F4 9.732 97.32 
F5 9.957 99.57 
F6 9.632 96.32 
F7 9.932 99.32 
F8 10.183 101.83 
F9 10.108 101.08 
F10 9.832 98.32 
F11 10.108 101.08 
F12 9.932 99.32 
F13 10.199 101.99 
F14 9.773 97.73 
F15 10.074 100.74 
F16 9.957 99.57 
F17 10.058 100.58 
F18 9.982 99.82 
F19 10.208 102.08 
F20 9.882 98.82 
Data are expressed as mean  S.D. (n = 3) 
 
The in vitro wetting time was also studied to know the time 
required for complete wetting of tablets when placed on 
tonge. The in-vitro wetting time of all the formulations were 
varied between 19±1 to 114±5. The results were shown in 
Table 8. The swelling properties of the superdisintegrant 
were depend upon their concentration and the results 
shows that as the concentration of the superdisintegrant 
increased the time taken for swallowing was reduced. The 
swelling time was rapid in Crospovidone followed by citric 
acid, Ac-Di-Sol and Sodium starch glycolate. The same 
sequence was observed in case of measurement of 
dispersion time of the tablet.The drug content of all the 
tablet formulations was determined spectrophotometrically 
at 260 nm. It varied from 9.632 to 10.208  mg per tablet. The 
correlation of variation was found to be less than 0.5, 
indicating uniformity of the drug content in the prepared 
tablets. The results of the content uniformity and percent 
drug content were shown in Table 9. 
In vitro drug release experiments were performed at 37±1oC 
in seven basket dissolution apparatus.. The maximum drug 
release was found in formulation F15 (96.264%). 
The order of drug release was found to be: 
F15>F20>F14>F10>F19>F13>F9>F5>F12>F18>F4>F8>
F11>F17>F3>F2>F16>F1>F7>F6 
Formulations F5, F10, F15 and F20 which contains 5% of 
Ac-Di-Sol, Sodium starch glycolate, Crospovidone and citric 
acid + sodium bicarbonate respectively. The release was 
estimated after five minutes was 81.1083%, 86.680%, 
96.264% and 93.116% respectively. The formulation with 
Crospovidone shows more release than the tablets with 
Citric acid, Ac-Di-Sol and Sodium starch glycolate. 
The disintegrant Crospovidone shows the faster 
disntegration than other. So release of drug and release rate 
was higher from these tablets. From the observed data, it 
can be clear that less time in disintegration enhance the 
release rate of Ketoprofen from Fast Dissolving Tablet.  
Formulations which show maximum drug release from each 
disintegrants and also having friability less than 0.9 % were 
selected for the stability studies. These include F4, F9, F15 
and F18. 
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6. CONCLUSION   . 
Compounds with poor aqueous solubility are extremely 
challenging to be developed as new formulations. It is well 
known that drug dissolution rather than permeation 
through the epithelia of the gastrointestional tract is 
responsible for a low oral absorption. One of the 
pharmaceutical strategies to improve the oral bioavailability 
is the formulation of solid dispersions. Ketoprofen was 
selected as model drug for the research work because it has 
a poor aqueous solubility and low dissolution rate, while 
high permeability. The model drug was formulated as 
physical mixture and solid dispersions with poloxamer 188 
in order to improve the drug dissolution. Ketoprofen-
poloxamer 188 solid dispersions were prepared by melt 
fusion technique. Solid dispersions were characterized for 
percent drug content, solubility, FT-IR, in vitro drug release 
studies and dissolution efficiency. Formulations containing 
Ketoprofen and poloxamer 188, solid dispersions in 1:4 
ratio (KS2) showed better dissolution rate and promising 
dissolution efficiency.The disintegration properties of tablet 
were observed as Crospovidone > Citric acid + Sodium 
bicarbonate >Sodium starch glycolate > Ac-Di-Sol. The rapid 
drug dissolution might be due to the easy and fast 
breakdown of tablet and rapid absorption of drug into the 
dissolution media.  
The drug release was  found as 
F15>F20>F14>F10>F19>F13>F9>F5>F12>F18>F4>F8>F1
1>F17>F3>F2>F16>F1>F7>F6 The selected tablets 
formulations which posses the best physical quality were 
Ac-Di-Sol 4% w/w (F4), Sodium starch glycolate 4% w/w 
(F9), Crospovidone 5% w/w (F15) and Sodium bicarbonate 
+citric acid (1:2) 5% w/w (F18). All prepared tablets 
followed First order kinetics for release of drug. On 
experimental data it was concluded that Fast dissolving 
tablet of Ketoprofen would be an effective alternative 
approach for management of various inflammatory 
disorders and pain. Superdisintegrant Crospovidone in 5% 
w/w concentration (F15) formulation is the most promising 
dosage form for rapid release of Ketoprofen. 
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